logo

Innovative Laser and Fiber System for Non-Toxic, Efficient and Cost-Effective Treatment of Cancer

Sector: Nuclear • Location: Germany

Source: EU Funding & Tenders Portal

Project
Ended

"Our aim with this proposal is to bring the desired technology for a non-toxic, efficient and cost-effective cancer treatment. Basically, all cytotoxic drugs (chemotherapy) and radiation lead to apoptosis, the programmed cell death of tumor cells. These techniques on the other hand have well documented side effects like losing hair, teeth, damaged quality of life effecting lives of more than 14M c

Project Information FAQ

Project Information

3 Q
The project “Innovative Laser and Fiber System for Non-Toxic, Efficient and Cost-Effective Treatment of Cancer” is an infrastructure initiative in the Nuclear sector, located in Germany. Taiyo aggregates data on it from EU Funding & Tenders Portal.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

ended

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

"Our aim with this proposal is to bring the desired technology for a non-toxic, efficient and cost-effective cancer treatment. Basically, all cytotoxic drugs (chemotherapy) and radiation lead to apoptosis, the programmed cell death of tumor cells. These techniques on the other hand have well documented side effects like losing hair, teeth, damaged quality of life effecting lives of more than 14M cancer patients and their families worldwide. LoF revolutionizes ""non-toxic"" cancer treatment with her innovative laser probes and systems serving oncologists tasked with saving lives by developing and applying the most effective therapies. Our state-of-the-art laser probes and systems form a feedback loop and enable oncologists for the “first time” to monitor absorbed dose to the tissue in real time which is decisive for the treatment efficacy. Cancer cost the EU €126 billion in 2013, with health care accounting for €51 billion (40% of the total cost) for post-treatments. EU needs better, effective solutions to drive costs down. With our solution which is the subject of this proposal we offer a potential cost-saving of 60%. The market potential for the envisaged the clinical applications is based on current cases at around 2.24 billion euros worldwide. Our innovation opens the door to new treatment applications and could be used to treat up to 5 million people per year from 2022."

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data